Latest news
FDA Approves First Ophthalmic Treatment for Wet AMD Leading Wainwright to Triple Price Target - Streetwise ReportsStreetwise Reports · Wed, 29 Jul 2026 07:00:00 GMTMicron Revenues Could Triple Again By 2030. Here’s the Math. - 24/7 Wall St.24/7 Wall St. · Wed, 29 Jul 2026 07:00:00 GMTShould You Buy Oracle Since it Promises 100% Upside at Consensus Target Price? - 24/7 Wall St.24/7 Wall St. · Wed, 29 Jul 2026 07:00:00 GMT